A Stepped-Wedge Cluster Randomized Trial of a Digital App to Support Medication-Assisted Treatment in Individuals With Opioid Use Disorder

NACompletedINTERVENTIONAL
Enrollment

1,524

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

November 1, 2024

Study Completion Date

December 31, 2024

Conditions
Opioid Use Disorder
Interventions
DEVICE

Recovery Connect

"Recovery Connect is a white-labeled version of the Recovery Path platform, rebranded to maintain partner organizations' brand identity while leveraging its established digital infrastructure. Recovery Path is a HIPAA-compliant remote patient monitoring system that supports a blended model of care for medication for opioid use disorder (MOUD), integrating in-person treatment with continuous digital engagement.~The app provides patients with daily check-ins, access to evidence-based resources and coping strategies, and secure messaging with their care teams. Clinicians receive real-time data on patient progress, risks, and setbacks. Between visits, clinicians can recommend tailored coping tools and psychoeducational content, reinforcing accountability and enhancing continuity of care.~RC is also integrated into the clinic's electronic medical record system to streamline workflows, reduce administrative burden, and improve documentation accuracy through auto-generated case notes."

Trial Locations (9)

58103

Community Medical Services, Fargo

58201

Community Medical Services, Grand Forks

58703

Community Medical Services, Minot

59102

Community Medical Services, Billings

59714

Community Medical Services, Bozeman

59801

Community Medical Services, Missoula

59901

Community Medical Services, Kalispell

99508

Community Medical Services, Anchorage

99654

Community Medical Services, Wasilla

Sponsors
All Listed Sponsors
collaborator

Community Medical Services

UNKNOWN

lead

Bright Therapeutics

INDUSTRY

NCT07140926 - A Stepped-Wedge Cluster Randomized Trial of a Digital App to Support Medication-Assisted Treatment in Individuals With Opioid Use Disorder | Biotech Hunter | Biotech Hunter